1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,140 | 0,184 | 11:46 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.09. | SIPAI HEALTH (00314): 2026 INTERIM REPORT | - | HKEx | ||
| 10.09. | SIPAI HEALTH (00314): COMPLETION ANNOUNCEMENT - DISCLOSEABLE TRANSACTION - ACQUISITION OF 100% EQUITY INTEREST IN JIANYI INFORMATION | - | HKEx | ||
| 10.09. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 07.09. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 3 | HKEx | ||
| 02.09. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 27.08. | SIPAI HEALTH (00314): DISCLOSEABLE TRANSACTION REDEMPTION OF WEALTH MANAGEMENT PRODUCT | - | HKEx | ||
| 26.08. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| SIPAI HEALTH TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 21.08. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 20.08. | SIPAI HEALTH (00314): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 1 | HKEx | ||
| 10.08. | SIPAI HEALTH (00314): DATE OF BOARD MEETING | 2 | HKEx | ||
| 04.08. | SIPAI HEALTH (00314): POSITIVE PROFIT ALERT - TURNAROUND FROM NET LOSS TO NET PROFIT | - | HKEx | ||
| 31.07. | SIPAI HEALTH (00314): DISCLOSEABLE TRANSACTION SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCT | 1 | HKEx | ||
| 16.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 15.07. | SIPAI HEALTH (00314): VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY EXECUTIVE DIRECTORS; AND ON-MARKET SHARE REPURCHASES BY THE COMPANY | - | HKEx | ||
| 13.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 08.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 06.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 30.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 2 | HKEx | ||
| 26.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 1 | HKEx | ||
| 23.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS | 42,525 | +2,25 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,630 | +2,48 % | Fresenius Medical Care Aktie: Wechsel an der Konzernspitze | Fresenius Medical Care bekommt kurzfristig einen neuen Vorstandschef. Shervin J. Korangy übernimmt mit Wirkung zum 12. Oktober 2026 den Vorsitz des Vorstands. Der Aufsichtsrat hat die Personalie am... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,820 | +1,46 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning |
Das Unternehmen SIPAI HEALTH TECHNOLOGY CO LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,140 Euro und damit 0,00 % im Plus. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIPAI HEALTH TECHNOLOGY CO LTD finden Sie auf Wallstreet Online.